| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Pessaries | 5 | 2018 | 32 | 2.99 | Why? |
| Premature Birth | 16 | 2020 | 2151 | 2.72 | Why? |
| Postpartum Hemorrhage | 4 | 2019 | 144 | 2.10 | Why? |
| Cervical Length Measurement | 7 | 2018 | 38 | 1.75 | Why? |
| Cervix Uteri | 5 | 2019 | 146 | 1.73 | Why? |
| Pregnancy, Twin | 4 | 2019 | 133 | 1.55 | Why? |
| Pregnancy | 85 | 2021 | 23879 | 1.46 | Why? |
| Fetal Diseases | 3 | 2019 | 182 | 1.45 | Why? |
| Endometrial Hyperplasia | 7 | 2020 | 8 | 1.42 | Why? |
| Fetal Membranes, Premature Rupture | 5 | 2020 | 122 | 1.37 | Why? |
| Massage | 2 | 2018 | 53 | 1.35 | Why? |
| Progestins | 4 | 2018 | 43 | 1.31 | Why? |
| Obstetrics and Gynecology Department, Hospital | 2 | 2020 | 241 | 1.30 | Why? |
| Cesarean Section | 15 | 2020 | 2089 | 1.29 | Why? |
| Fertilization in Vitro | 3 | 2018 | 330 | 1.21 | Why? |
| Diabetes, Gestational | 5 | 2019 | 426 | 0.95 | Why? |
| Delivery, Obstetric | 9 | 2020 | 1292 | 0.85 | Why? |
| Labor, Induced | 3 | 2020 | 186 | 0.84 | Why? |
| Oxytocin | 2 | 2019 | 76 | 0.84 | Why? |
| Lymphangioma, Cystic | 1 | 2019 | 6 | 0.80 | Why? |
| Embryo Implantation | 3 | 2018 | 59 | 0.80 | Why? |
| Urethral Obstruction | 1 | 2019 | 5 | 0.80 | Why? |
| Pregnancy Complications, Infectious | 12 | 2021 | 11559 | 0.79 | Why? |
| Labor, Obstetric | 6 | 2020 | 257 | 0.77 | Why? |
| Cerclage, Cervical | 2 | 2019 | 17 | 0.76 | Why? |
| Thoracic Wall | 1 | 2019 | 54 | 0.75 | Why? |
| Endometrial Neoplasms | 5 | 2020 | 120 | 0.74 | Why? |
| Labor Stage, Third | 1 | 2017 | 3 | 0.73 | Why? |
| Ultrasonography, Prenatal | 9 | 2020 | 471 | 0.73 | Why? |
| Labor Stage, Second | 1 | 2017 | 12 | 0.73 | Why? |
| Uterine Diseases | 1 | 2017 | 13 | 0.72 | Why? |
| Tocolytic Agents | 1 | 2017 | 23 | 0.72 | Why? |
| Oxytocics | 1 | 2017 | 47 | 0.70 | Why? |
| Pregnant Women | 4 | 2021 | 2535 | 0.69 | Why? |
| Antifibrinolytic Agents | 1 | 2019 | 150 | 0.68 | Why? |
| Soft Tissue Neoplasms | 1 | 2019 | 131 | 0.68 | Why? |
| Tranexamic Acid | 1 | 2019 | 121 | 0.68 | Why? |
| Pregnancy Outcome | 15 | 2021 | 3803 | 0.65 | Why? |
| Twins | 1 | 2017 | 115 | 0.65 | Why? |
| Randomized Controlled Trials as Topic | 26 | 2019 | 10649 | 0.58 | Why? |
| Outpatient Clinics, Hospital | 1 | 2020 | 523 | 0.57 | Why? |
| Withholding Treatment | 2 | 2017 | 798 | 0.55 | Why? |
| Abortion, Spontaneous | 5 | 2020 | 776 | 0.54 | Why? |
| Obstetric Labor Complications | 3 | 2019 | 119 | 0.51 | Why? |
| Progesterone | 3 | 2018 | 106 | 0.50 | Why? |
| Antibodies, Antiphospholipid | 1 | 2017 | 519 | 0.47 | Why? |
| Semen | 1 | 2017 | 550 | 0.46 | Why? |
| Pre-Eclampsia | 4 | 2020 | 599 | 0.46 | Why? |
| Pregnancy Complications | 3 | 2017 | 1388 | 0.44 | Why? |
| Uterus | 4 | 2019 | 98 | 0.44 | Why? |
| Female | 97 | 2021 | 380317 | 0.43 | Why? |
| Gestational Age | 8 | 2020 | 1488 | 0.43 | Why? |
| Antiphospholipid Syndrome | 1 | 2017 | 533 | 0.42 | Why? |
| Exercise | 4 | 2018 | 6771 | 0.41 | Why? |
| Cardiotocography | 3 | 2018 | 40 | 0.40 | Why? |
| Precancerous Conditions | 3 | 2019 | 108 | 0.39 | Why? |
| Lacerations | 2 | 2019 | 35 | 0.38 | Why? |
| PTEN Phosphohydrolase | 2 | 2019 | 70 | 0.38 | Why? |
| Uterine Rupture | 2 | 2018 | 15 | 0.37 | Why? |
| Chewing Gum | 2 | 2019 | 18 | 0.37 | Why? |
| Ambulatory Care Facilities | 1 | 2020 | 2063 | 0.36 | Why? |
| Endometrium | 2 | 2018 | 68 | 0.35 | Why? |
| Infertility, Female | 3 | 2018 | 150 | 0.35 | Why? |
| Fetal Growth Retardation | 3 | 2020 | 217 | 0.35 | Why? |
| Uterine Neoplasms | 2 | 2018 | 70 | 0.34 | Why? |
| Atrioventricular Block | 2 | 2018 | 105 | 0.33 | Why? |
| Stillbirth | 4 | 2020 | 544 | 0.32 | Why? |
| Infant, Newborn | 16 | 2021 | 23105 | 0.32 | Why? |
| Pregnancy Trimester, Second | 5 | 2019 | 314 | 0.32 | Why? |
| Endometriosis | 2 | 2018 | 130 | 0.31 | Why? |
| Hypertension, Pregnancy-Induced | 2 | 2018 | 208 | 0.30 | Why? |
| Pregnancy Rate | 4 | 2018 | 134 | 0.30 | Why? |
| Vagina | 2 | 2017 | 327 | 0.28 | Why? |
| Counseling | 2 | 2021 | 747 | 0.28 | Why? |
| Humans | 99 | 2021 | 930598 | 0.27 | Why? |
| Perinatal Death | 3 | 2020 | 372 | 0.26 | Why? |
| Immunoglobulin M | 2 | 2020 | 9091 | 0.25 | Why? |
| Perinatal Care | 2 | 2020 | 576 | 0.25 | Why? |
| Glucose Tolerance Test | 3 | 2019 | 238 | 0.25 | Why? |
| Fetal Macrosomia | 2 | 2017 | 16 | 0.23 | Why? |
| Administration, Intravaginal | 2 | 2017 | 38 | 0.23 | Why? |
| Twins, Monozygotic | 2 | 2019 | 83 | 0.23 | Why? |
| Mass Screening | 3 | 2020 | 8005 | 0.22 | Why? |
| Heart Rate, Fetal | 2 | 2018 | 38 | 0.22 | Why? |
| Obstetrics | 2 | 2020 | 859 | 0.22 | Why? |
| Abortion, Induced | 2 | 2018 | 437 | 0.22 | Why? |
| Prenatal Care | 4 | 2020 | 1314 | 0.21 | Why? |
| Hypertelorism | 1 | 2019 | 1 | 0.21 | Why? |
| Fetal Death | 2 | 2020 | 390 | 0.21 | Why? |
| Amniotomy | 1 | 2019 | 4 | 0.21 | Why? |
| Pregnancy, Cornual | 1 | 2019 | 1 | 0.20 | Why? |
| Perinatology | 1 | 2020 | 59 | 0.20 | Why? |
| Cervical Ripening | 1 | 2019 | 25 | 0.20 | Why? |
| Urogenital Abnormalities | 1 | 2019 | 10 | 0.20 | Why? |
| Placenta Previa | 1 | 2019 | 21 | 0.20 | Why? |
| Placenta Accreta | 1 | 2019 | 24 | 0.20 | Why? |
| Alprostadil | 1 | 2018 | 8 | 0.20 | Why? |
| Steroids, Fluorinated | 1 | 2018 | 3 | 0.20 | Why? |
| Postnatal Care | 2 | 2020 | 346 | 0.20 | Why? |
| Adenocarcinoma, Mucinous | 1 | 2019 | 27 | 0.20 | Why? |
| Coitus | 1 | 2019 | 44 | 0.19 | Why? |
| Hyperplasia | 1 | 2020 | 204 | 0.19 | Why? |
| Genetic Carrier Screening | 1 | 2018 | 18 | 0.19 | Why? |
| Uterine Cervical Neoplasms | 2 | 2019 | 842 | 0.19 | Why? |
| Contraception Behavior | 1 | 2019 | 60 | 0.19 | Why? |
| Live Birth | 2 | 2018 | 200 | 0.19 | Why? |
| Endometritis | 1 | 2018 | 12 | 0.19 | Why? |
| Pregnancy, Angular | 1 | 2018 | 1 | 0.19 | Why? |
| Hydrops Fetalis | 1 | 2018 | 33 | 0.19 | Why? |
| Insemination, Artificial | 1 | 2018 | 10 | 0.19 | Why? |
| Tissue Adhesions | 1 | 2018 | 33 | 0.19 | Why? |
| Myoma | 1 | 2017 | 2 | 0.19 | Why? |
| Preconception Care | 1 | 2018 | 49 | 0.19 | Why? |
| Hysteroscopy | 1 | 2018 | 11 | 0.19 | Why? |
| Postmortem Changes | 1 | 2019 | 133 | 0.18 | Why? |
| Labor Stage, First | 1 | 2017 | 5 | 0.18 | Why? |
| Uterine Contraction | 1 | 2017 | 12 | 0.18 | Why? |
| Cleft Lip | 1 | 2019 | 76 | 0.18 | Why? |
| Sexual Dysfunction, Physiological | 1 | 2019 | 89 | 0.18 | Why? |
| Abortion, Habitual | 1 | 2018 | 35 | 0.18 | Why? |
| Cleft Palate | 1 | 2019 | 81 | 0.18 | Why? |
| Gonadotropin-Releasing Hormone | 1 | 2018 | 53 | 0.18 | Why? |
| Ovulation Induction | 1 | 2018 | 58 | 0.18 | Why? |
| Urinary Catheterization | 1 | 2018 | 47 | 0.18 | Why? |
| Combined Modality Therapy | 2 | 2017 | 3395 | 0.18 | Why? |
| Perinatal Mortality | 1 | 2019 | 120 | 0.18 | Why? |
| Embryo Transfer | 1 | 2018 | 91 | 0.18 | Why? |
| Surgical Wound Dehiscence | 1 | 2017 | 18 | 0.18 | Why? |
| Hyperemesis Gravidarum | 1 | 2017 | 5 | 0.18 | Why? |
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2018 | 127 | 0.18 | Why? |
| Mifepristone | 1 | 2018 | 93 | 0.18 | Why? |
| Oocyte Retrieval | 1 | 2017 | 44 | 0.18 | Why? |
| Pituitary Gland | 1 | 2018 | 65 | 0.18 | Why? |
| Fertilization | 1 | 2017 | 49 | 0.18 | Why? |
| Forensic Pathology | 1 | 2019 | 109 | 0.18 | Why? |
| Heparin, Low-Molecular-Weight | 2 | 2018 | 1731 | 0.17 | Why? |
| Fetal Weight | 1 | 2017 | 24 | 0.17 | Why? |
| Urinary Bladder | 1 | 2019 | 170 | 0.17 | Why? |
| Betamethasone | 1 | 2017 | 63 | 0.17 | Why? |
| Fetal Heart | 1 | 2017 | 46 | 0.17 | Why? |
| Leiomyoma | 1 | 2017 | 59 | 0.17 | Why? |
| Pregnancy in Diabetics | 1 | 2017 | 56 | 0.17 | Why? |
| beta 2-Glycoprotein I | 1 | 2017 | 92 | 0.17 | Why? |
| Vascular Malformations | 1 | 2017 | 52 | 0.17 | Why? |
| Gastrointestinal Motility | 1 | 2017 | 78 | 0.17 | Why? |
| Version, Fetal | 1 | 2016 | 5 | 0.16 | Why? |
| Immunohistochemistry | 3 | 2019 | 2275 | 0.16 | Why? |
| Isotonic Solutions | 1 | 2017 | 69 | 0.16 | Why? |
| Obstetric Labor, Premature | 1 | 2018 | 114 | 0.16 | Why? |
| Arterial Pressure | 1 | 2018 | 208 | 0.16 | Why? |
| Immunoglobulin G | 2 | 2020 | 21571 | 0.16 | Why? |
| Breech Presentation | 1 | 2016 | 20 | 0.16 | Why? |
| Abortion, Legal | 1 | 2017 | 67 | 0.16 | Why? |
| Cicatrix | 1 | 2017 | 129 | 0.16 | Why? |
| Suture Techniques | 1 | 2017 | 138 | 0.15 | Why? |
| Life Support Care | 1 | 2017 | 161 | 0.15 | Why? |
| Family Planning Services | 1 | 2019 | 236 | 0.15 | Why? |
| Reproductive Techniques, Assisted | 2 | 2017 | 400 | 0.15 | Why? |
| Genetic Counseling | 1 | 2018 | 229 | 0.15 | Why? |
| Early Detection of Cancer | 2 | 2018 | 1956 | 0.15 | Why? |
| Prenatal Diagnosis | 1 | 2018 | 345 | 0.15 | Why? |
| Fetus | 1 | 2019 | 484 | 0.14 | Why? |
| Portugal | 1 | 2020 | 1265 | 0.14 | Why? |
| Adult | 24 | 2021 | 244371 | 0.14 | Why? |
| Pain, Postoperative | 1 | 2018 | 289 | 0.14 | Why? |
| Postpartum Period | 2 | 2018 | 936 | 0.14 | Why? |
| Analgesics | 1 | 2018 | 451 | 0.14 | Why? |
| Italy | 7 | 2021 | 38444 | 0.14 | Why? |
| Povidone-Iodine | 1 | 2017 | 213 | 0.14 | Why? |
| Infertility | 1 | 2017 | 247 | 0.13 | Why? |
| Food | 1 | 2017 | 316 | 0.13 | Why? |
| Eating | 1 | 2017 | 395 | 0.13 | Why? |
| Glucose | 1 | 2018 | 573 | 0.13 | Why? |
| Pain | 2 | 2019 | 1084 | 0.13 | Why? |
| Secondary Prevention | 1 | 2019 | 762 | 0.13 | Why? |
| Gynecologic Surgical Procedures | 1 | 2018 | 489 | 0.13 | Why? |
| Fluid Therapy | 1 | 2018 | 628 | 0.13 | Why? |
| Fertility | 1 | 2017 | 367 | 0.13 | Why? |
| Analgesia | 1 | 2016 | 211 | 0.13 | Why? |
| Gynecology | 1 | 2020 | 741 | 0.12 | Why? |
| Diagnostic Errors | 1 | 2019 | 865 | 0.12 | Why? |
| Brain Injuries | 1 | 2017 | 374 | 0.12 | Why? |
| Analgesics, Opioid | 2 | 2018 | 1070 | 0.12 | Why? |
| Surgical Wound Infection | 1 | 2017 | 501 | 0.11 | Why? |
| Primary Prevention | 1 | 2019 | 778 | 0.11 | Why? |
| Postoperative Care | 1 | 2017 | 755 | 0.11 | Why? |
| Preoperative Care | 2 | 2018 | 1515 | 0.11 | Why? |
| Infectious Disease Transmission, Vertical | 4 | 2021 | 5164 | 0.11 | Why? |
| Placenta | 2 | 2019 | 1531 | 0.11 | Why? |
| Neoplasm Recurrence, Local | 1 | 2018 | 1063 | 0.11 | Why? |
| Patient Education as Topic | 1 | 2021 | 1476 | 0.11 | Why? |
| Infection Control | 1 | 2020 | 23131 | 0.11 | Why? |
| Anti-Infective Agents, Local | 1 | 2017 | 520 | 0.11 | Why? |
| Coronavirus Infections | 7 | 2020 | 253789 | 0.11 | Why? |
| Pneumonia, Viral | 6 | 2020 | 243684 | 0.11 | Why? |
| L-Lactate Dehydrogenase | 1 | 2018 | 1995 | 0.10 | Why? |
| Workflow | 1 | 2020 | 2373 | 0.10 | Why? |
| Sexual Behavior | 1 | 2019 | 1322 | 0.10 | Why? |
| Episiotomy | 2 | 2019 | 10 | 0.10 | Why? |
| Young Adult | 13 | 2019 | 93724 | 0.10 | Why? |
| Betacoronavirus | 5 | 2020 | 204454 | 0.10 | Why? |
| Risk Factors | 11 | 2020 | 71621 | 0.10 | Why? |
| Perineum | 2 | 2019 | 70 | 0.09 | Why? |
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2018 | 1454 | 0.09 | Why? |
| Retrospective Studies | 13 | 2021 | 105322 | 0.09 | Why? |
| Aspirin | 1 | 2017 | 1043 | 0.09 | Why? |
| Abortifacient Agents, Nonsteroidal | 2 | 2018 | 60 | 0.09 | Why? |
| Kaplan-Meier Estimate | 1 | 2017 | 4260 | 0.09 | Why? |
| Treatment Outcome | 7 | 2018 | 51732 | 0.09 | Why? |
| Practice Guidelines as Topic | 3 | 2020 | 15421 | 0.08 | Why? |
| Pregnancy Trimester, First | 2 | 2019 | 366 | 0.08 | Why? |
| Platelet Aggregation Inhibitors | 1 | 2017 | 1671 | 0.08 | Why? |
| Anticoagulants | 2 | 2018 | 9563 | 0.08 | Why? |
| Incidence | 5 | 2018 | 25622 | 0.07 | Why? |
| Clinical Competence | 1 | 2020 | 3263 | 0.07 | Why? |
| Hypoglycemic Agents | 1 | 2017 | 2165 | 0.07 | Why? |
| Time Factors | 5 | 2019 | 31397 | 0.07 | Why? |
| Intensive Care Units, Neonatal | 2 | 2021 | 749 | 0.07 | Why? |
| Triage | 2 | 2020 | 7151 | 0.07 | Why? |
| Liver Transplantation | 1 | 2019 | 2864 | 0.06 | Why? |
| Infusions, Intravenous | 2 | 2018 | 1224 | 0.06 | Why? |
| Cohort Studies | 4 | 2020 | 36005 | 0.06 | Why? |
| Glucocorticoids | 1 | 2018 | 4431 | 0.06 | Why? |
| World Health Organization | 3 | 2020 | 4213 | 0.06 | Why? |
| Pandemics | 6 | 2020 | 389249 | 0.06 | Why? |
| Biomarkers | 3 | 2018 | 23361 | 0.05 | Why? |
| Hypospadias | 1 | 2019 | 8 | 0.05 | Why? |
| Contraceptive Devices, Female | 1 | 2019 | 11 | 0.05 | Why? |
| Psychopathology | 1 | 2020 | 107 | 0.05 | Why? |
| Fetal Monitoring | 1 | 2020 | 80 | 0.05 | Why? |
| Students, Medical | 1 | 2019 | 4032 | 0.05 | Why? |
| Genes, bcl-2 | 1 | 2019 | 3 | 0.05 | Why? |
| Ambulatory Care | 1 | 2017 | 4947 | 0.05 | Why? |
| Contraceptives, Oral, Hormonal | 1 | 2019 | 42 | 0.05 | Why? |
| Anesthesia, Epidural | 1 | 2020 | 92 | 0.05 | Why? |
| Umbilical Arteries | 1 | 2019 | 62 | 0.05 | Why? |
| Proto-Oncogene Proteins c-met | 1 | 2019 | 40 | 0.05 | Why? |
| Internship and Residency | 1 | 2020 | 4987 | 0.05 | Why? |
| Pulsatile Flow | 1 | 2019 | 123 | 0.05 | Why? |
| South America | 1 | 2021 | 565 | 0.05 | Why? |
| Fallopian Tubes | 1 | 2018 | 13 | 0.05 | Why? |
| Hematocrit | 1 | 2018 | 107 | 0.05 | Why? |
| Hepatocyte Growth Factor | 1 | 2019 | 71 | 0.05 | Why? |
| Isoenzymes | 1 | 2018 | 127 | 0.05 | Why? |
| Follicle Stimulating Hormone | 1 | 2018 | 73 | 0.05 | Why? |
| Postoperative Complications | 1 | 2017 | 5861 | 0.05 | Why? |
| MEDLINE | 1 | 2018 | 76 | 0.05 | Why? |
| Middle Cerebral Artery | 1 | 2019 | 128 | 0.05 | Why? |
| Chorionic Gonadotropin, beta Subunit, Human | 1 | 2018 | 27 | 0.05 | Why? |
| Sutures | 1 | 2018 | 57 | 0.05 | Why? |
| Myometrium | 1 | 2017 | 15 | 0.05 | Why? |
| Basophils | 1 | 2019 | 179 | 0.05 | Why? |
| Karyotyping | 1 | 2017 | 52 | 0.04 | Why? |
| Chromosome Disorders | 1 | 2017 | 24 | 0.04 | Why? |
| Esophagus | 1 | 2019 | 139 | 0.04 | Why? |
| Pregnancy, Multiple | 1 | 2017 | 46 | 0.04 | Why? |
| Hysterectomy | 1 | 2019 | 171 | 0.04 | Why? |
| Birth Weight | 1 | 2019 | 250 | 0.04 | Why? |
| Ovary | 1 | 2018 | 133 | 0.04 | Why? |
| Acidosis | 1 | 2018 | 125 | 0.04 | Why? |
| Abnormalities, Multiple | 1 | 2017 | 75 | 0.04 | Why? |
| Electrodes | 1 | 2018 | 203 | 0.04 | Why? |
| Magnetic Resonance Imaging | 3 | 2019 | 6551 | 0.04 | Why? |
| Birth Rate | 1 | 2018 | 137 | 0.04 | Why? |
| STAT3 Transcription Factor | 1 | 2019 | 268 | 0.04 | Why? |
| Pregnancy, Ectopic | 1 | 2017 | 82 | 0.04 | Why? |
| Diabetes Mellitus | 1 | 2019 | 8207 | 0.04 | Why? |
| Genetic Diseases, X-Linked | 1 | 2019 | 237 | 0.04 | Why? |
| Antiemetics | 1 | 2017 | 75 | 0.04 | Why? |
| Parity | 1 | 2017 | 122 | 0.04 | Why? |
| Laparoscopy | 2 | 2018 | 1532 | 0.04 | Why? |
| Postoperative Period | 1 | 2019 | 651 | 0.04 | Why? |
| Anesthesia, Obstetrical | 1 | 2020 | 230 | 0.04 | Why? |
| Anesthesia, Spinal | 1 | 2018 | 178 | 0.04 | Why? |
| Philadelphia | 1 | 2018 | 454 | 0.04 | Why? |
| Cell Nucleus | 1 | 2019 | 399 | 0.04 | Why? |
| Life Style | 2 | 2019 | 2708 | 0.04 | Why? |
| Severe Acute Respiratory Syndrome | 1 | 2020 | 12361 | 0.04 | Why? |
| Obesity | 1 | 2017 | 7388 | 0.04 | Why? |
| Ultrasonography, Doppler | 1 | 2019 | 406 | 0.04 | Why? |
| Analgesia, Epidural | 1 | 2016 | 63 | 0.04 | Why? |
| Laryngopharyngeal Reflux | 1 | 2017 | 78 | 0.04 | Why? |
| Pain Measurement | 1 | 2018 | 533 | 0.04 | Why? |
| Infant, Premature | 1 | 2020 | 883 | 0.04 | Why? |
| Conservative Treatment | 1 | 2018 | 349 | 0.04 | Why? |
| Brain Death | 1 | 2017 | 146 | 0.04 | Why? |
| Neovascularization, Pathologic | 1 | 2019 | 305 | 0.04 | Why? |
| Vascular Endothelial Growth Factor A | 1 | 2019 | 604 | 0.03 | Why? |
| Chi-Square Distribution | 1 | 2017 | 961 | 0.03 | Why? |
| Diagnosis, Differential | 2 | 2019 | 7220 | 0.03 | Why? |
| Methotrexate | 1 | 2018 | 471 | 0.03 | Why? |
| Asia | 1 | 2021 | 2399 | 0.03 | Why? |
| Acupuncture Therapy | 1 | 2017 | 234 | 0.03 | Why? |
| Bias | 1 | 2019 | 1109 | 0.03 | Why? |
| Educational Status | 1 | 2019 | 1451 | 0.03 | Why? |
| Visitors to Patients | 1 | 2020 | 671 | 0.03 | Why? |
| Maternal Health | 1 | 2017 | 331 | 0.03 | Why? |
| Patient Preference | 1 | 2019 | 750 | 0.03 | Why? |
| Treatment Failure | 1 | 2018 | 2106 | 0.03 | Why? |
| Vomiting | 1 | 2017 | 722 | 0.03 | Why? |
| Lung | 2 | 2019 | 31049 | 0.03 | Why? |
| Stents | 1 | 2019 | 916 | 0.03 | Why? |
| Brain | 2 | 2019 | 5133 | 0.03 | Why? |
| Ultrasonography | 2 | 2018 | 4409 | 0.03 | Why? |
| Hemodynamics | 1 | 2019 | 1562 | 0.03 | Why? |
| HIV Infections | 1 | 2016 | 11620 | 0.03 | Why? |
| Drug Administration Schedule | 1 | 2017 | 2324 | 0.03 | Why? |
| Overweight | 1 | 2017 | 916 | 0.03 | Why? |
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2020 | 13720 | 0.03 | Why? |
| Breast Feeding | 1 | 2020 | 1585 | 0.02 | Why? |
| Biomarkers, Tumor | 1 | 2018 | 1314 | 0.02 | Why? |
| Patient Compliance | 1 | 2019 | 1468 | 0.02 | Why? |
| Patient Readmission | 1 | 2018 | 1543 | 0.02 | Why? |
| Apoptosis | 1 | 2019 | 2335 | 0.02 | Why? |
| Membrane Proteins | 1 | 2019 | 1733 | 0.02 | Why? |
| Dose-Response Relationship, Drug | 1 | 2017 | 3776 | 0.02 | Why? |
| Recurrence | 1 | 2018 | 3675 | 0.02 | Why? |
| Alcohol Drinking | 1 | 2019 | 1663 | 0.02 | Why? |
| Australia | 1 | 2021 | 6306 | 0.02 | Why? |
| Pain Management | 1 | 2016 | 854 | 0.02 | Why? |
| Male | 5 | 2020 | 367725 | 0.02 | Why? |
| ROC Curve | 1 | 2019 | 6024 | 0.02 | Why? |
| Patient Isolation | 1 | 2020 | 3182 | 0.02 | Why? |
| Antihypertensive Agents | 1 | 2018 | 1962 | 0.02 | Why? |
| Smoking | 1 | 2019 | 3358 | 0.02 | Why? |
| Odds Ratio | 1 | 2017 | 5861 | 0.02 | Why? |
| Patient Satisfaction | 1 | 2018 | 2517 | 0.02 | Why? |
| Risk | 1 | 2018 | 5288 | 0.02 | Why? |
| Drug Therapy, Combination | 1 | 2018 | 7268 | 0.02 | Why? |
| Evidence-Based Medicine | 1 | 2017 | 3228 | 0.02 | Why? |
| Europe | 1 | 2021 | 12702 | 0.02 | Why? |
| Patient Discharge | 1 | 2020 | 5696 | 0.02 | Why? |
| Risk Assessment | 2 | 2019 | 25439 | 0.02 | Why? |
| Clinical Laboratory Techniques | 2 | 2020 | 23402 | 0.02 | Why? |
| Chronic Disease | 1 | 2018 | 5139 | 0.02 | Why? |
| Blood Glucose | 1 | 2017 | 3642 | 0.02 | Why? |
| Comorbidity | 2 | 2019 | 34796 | 0.02 | Why? |
| Predictive Value of Tests | 1 | 2018 | 9537 | 0.02 | Why? |
| Length of Stay | 1 | 2020 | 11042 | 0.01 | Why? |
| Socioeconomic Factors | 1 | 2019 | 8495 | 0.01 | Why? |
| Health Behavior | 1 | 2019 | 4449 | 0.01 | Why? |
| Tertiary Care Centers | 1 | 2017 | 8248 | 0.01 | Why? |
| Disease Progression | 1 | 2018 | 13580 | 0.01 | Why? |
| Acute Kidney Injury | 1 | 2018 | 5762 | 0.01 | Why? |
| Middle East Respiratory Syndrome Coronavirus | 1 | 2020 | 8843 | 0.01 | Why? |
| Adolescent | 2 | 2019 | 86841 | 0.01 | Why? |
| Sensitivity and Specificity | 1 | 2018 | 22971 | 0.01 | Why? |
| Health Knowledge, Attitudes, Practice | 1 | 2019 | 8811 | 0.01 | Why? |
| SARS Virus | 1 | 2020 | 13021 | 0.01 | Why? |
| Critical Illness | 1 | 2020 | 17281 | 0.01 | Why? |
| Quality of Life | 1 | 2017 | 9820 | 0.01 | Why? |
| Middle Aged | 3 | 2019 | 270681 | 0.01 | Why? |
| Personal Protective Equipment | 1 | 2020 | 15978 | 0.01 | Why? |
| Prognosis | 1 | 2019 | 32490 | 0.01 | Why? |
| Global Health | 1 | 2017 | 13911 | 0.01 | Why? |
| Tomography, X-Ray Computed | 1 | 2018 | 25144 | 0.01 | Why? |
| United States | 1 | 2017 | 46150 | 0.01 | Why? |
| Animals | 1 | 2019 | 78931 | 0.01 | Why? |
| Hospitalization | 1 | 2020 | 54280 | 0.01 | Why? |
| Telemedicine | 1 | 2020 | 25032 | 0.01 | Why? |
| Antiviral Agents | 1 | 2020 | 41703 | 0.01 | Why? |